Pituitrin for Concentrating Diodrast in Excretion Urography

The possible role of an antidiuretic hormone analogue, DDAVP (1 deamino-8-D-arginine vasopressin), in intravenous urography has been studied. The minimum effective dose of intravenous DDAVP in normal hydrated subjects was shown to be 2 ng/kg. During intravenous urography in fluid restricted subjects, a dose of 1 microgram DDAVP was necessary to reduce significantly the urine flow rate after contrast medium injection. Although the mean pyelographic score after DDAVP was increased, the differences observed were not statistically significant. The possible reasons for this finding are discussed.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pituitrin for Concentrating Diodrast in Excretion Urography

Cited by 2 publications

References 0 publications

An evaluation of Anti-Diuretic Hormone in intravenous urography “sniff urography”

An evaluation of Anti-Diuretic Hormone in intravenous urography “sniff urography”

The effect of DDAVP on intravenous urography

Contact Info

Product

Resources

About